Última Hora: "Bloco pede apoio urgente para as pessoas afetadas pelos fogos - Notícias ao Minuto" Fri, 20 Oct 2017 16:54:47 GMT   "Altice acusa NOS de não aceitar a livre concorrência como regra do jogo - Expresso" Fri, 20 Oct 2017 18:06:00 GMT    "Sardinha. Setor alega que parecer científico é um ?insulto? aos sacrifícios dos pescadores - Observador" Fri, 20 Oct 2017 14:06:00 GMT    "Crianças que não comeram frango cru tinham ?arroz banhado em sangue? - TVI24" Fri, 20 Oct 2017 12:29:21 GMT    "Mota-Engil informa que a Lineas vendeu participações na SCUTVIAS e PORTVIAS - RTP" Fri, 20 Oct 2017 16:27:00 GMT    "Novo Banco coloca PME como prioridade - Dinheiro Vivo" Thu, 19 Oct 2017 16:22:52 GMT    "TAP vai contratar 400 para abrir novas rotas. E não só no Porto - Dinheiro Vivo" Fri, 20 Oct 2017 07:29:23 GMT    "Governo aprova carta de condução para motos a partir dos 14 anos - Público.pt" Thu, 19 Oct 2017 14:30:31 GMT    "Infante. Vem aí o primeiro satélite criado em Portugal - Diário de Notícias - Lisboa" Wed, 18 Oct 2017 21:54:00 GMT    "Assembleia-Geral dos credores da operadora brasileira Oi foi adiada para novembro - Dinheiro Vivo" Sat, 21 Oct 2017 00:17:36 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Asthma Medication Market 2017 ? Dulera, QVAR, Genentech Inc, Sepracor, Inc
First News Service
Worldwide Asthma Medication Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Asthma Medication piece of the overall industry and Growth patterns, concentrating on driving Asthma ...

e mais »

Thinking About the Assessment of Risk: September 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


New report shares details about the asthma medication market forecast to 2022
WhaTech
Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The report also details the market positioning, ...

e mais »

biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer
Marketwired (press release)
VANCOUVER, BC--(Marketwired - August 21, 2017) - BIOASIS TECHNOLOGIES INC. ( OTCQB : BIOAF) (TSX VENTURE: BTI) ... He has also held various positions of increasing responsibility at Pfizer, Johnson & Johnson, Elan, Sepracor and Kadmon over his 20 year ...

e mais »

Desloratadine Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic ...
MilTech
Desloratadine Market Key Players Analysis: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
?With their successful partnership from their time at Sepracor, Bill and our CMO, Dr. Tom Wessel, are a great team to rapidly advance our Phase 2 clinical trials in MS, ALS and Charcot-Marie-Tooth with FLX-787 which will be amongst the most advanced ...

e mais »

InvestorGuide

Cynapsus Therapeutics (CYNA) Stock Doubles on Sunovion Buyout
InvestorGuide
Shares of Cynapsus Therapeutics Inc. (CYNA) were trading up +21.44 or +116.78 percent to $39.80 per share in Thursday's premarket after news broke late yesterday that it would be acquired by Sunovion Pharmaceuticals Inc. Cynapsus Therapeutics stock ...
Sunovion Pharmaceuticals to Acquire Cynapsus TherapeuticsBusiness Wire (press release)

todos os 98 artigos de notícias »

PR Newswire (press release)

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...
PR Newswire (press release)
Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


TheChronicleHerald.ca (registration)

PEI's BioVectra buys former Sepracor plant in Windsor
TheChronicleHerald.ca (registration)
A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ...
Charlottetown's BioVectra expanding, setting up in WindsorHants Journal

todos os 5 artigos de notícias »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
Sepracor, based in Marlborough, Massachusetts, had 2008 sales of $1.3 billion. Financial advisers to Dainippon Sumitomo were Nomura Securities and Thomas Weisel Partners LLC, while JP Morgan Securities Inc and Jeffries & Co advised Sepracor.


Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters